CN105194014A - Preparation and method for preventing and treating cerebral apoplexy (cerebral stroke) through eye dosing - Google Patents
Preparation and method for preventing and treating cerebral apoplexy (cerebral stroke) through eye dosing Download PDFInfo
- Publication number
- CN105194014A CN105194014A CN201410281172.0A CN201410281172A CN105194014A CN 105194014 A CN105194014 A CN 105194014A CN 201410281172 A CN201410281172 A CN 201410281172A CN 105194014 A CN105194014 A CN 105194014A
- Authority
- CN
- China
- Prior art keywords
- apoplexy
- preparation
- cerebral
- grams
- carried out
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000006011 Stroke Diseases 0.000 title claims abstract description 41
- 206010008190 Cerebrovascular accident Diseases 0.000 title claims abstract description 38
- 238000000034 method Methods 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 230000002490 cerebral effect Effects 0.000 title claims abstract description 8
- 238000001914 filtration Methods 0.000 claims abstract description 24
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 17
- 230000001954 sterilising effect Effects 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 201000001429 Intracranial Thrombosis Diseases 0.000 claims abstract description 6
- 210000001367 artery Anatomy 0.000 claims abstract description 6
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 claims abstract description 5
- 206010008132 Cerebral thrombosis Diseases 0.000 claims abstract description 5
- 206010020772 Hypertension Diseases 0.000 claims abstract description 5
- 210000001627 cerebral artery Anatomy 0.000 claims abstract description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 24
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims description 23
- 238000004659 sterilization and disinfection Methods 0.000 claims description 16
- 238000002137 ultrasound extraction Methods 0.000 claims description 15
- 241000628997 Flos Species 0.000 claims description 14
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 9
- 241000180649 Panax notoginseng Species 0.000 claims description 9
- 241000237636 Pheretima Species 0.000 claims description 9
- 241000228245 Aspergillus niger Species 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 8
- 241000190633 Cordyceps Species 0.000 claims description 8
- 241000271042 Gloydius halys Species 0.000 claims description 8
- 241000466341 Hemsleya sphaerocarpa Species 0.000 claims description 8
- 241000186660 Lactobacillus Species 0.000 claims description 8
- 238000000855 fermentation Methods 0.000 claims description 8
- 230000004151 fermentation Effects 0.000 claims description 8
- 229940039696 lactobacillus Drugs 0.000 claims description 8
- 241000283956 Manis Species 0.000 claims description 7
- 208000029078 coronary artery disease Diseases 0.000 claims description 5
- 208000034189 Sclerosis Diseases 0.000 claims description 4
- 208000026758 coronary atherosclerosis Diseases 0.000 claims description 4
- 210000004220 fundus oculi Anatomy 0.000 claims description 4
- 210000004204 blood vessel Anatomy 0.000 claims description 2
- SZGZILRQIYNODJ-UHFFFAOYSA-L disodium;7,12-dihydroquinoxalino[3,2-b]phenazine-2,9-disulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC=C2N=C(C=C3C(NC4=CC=C(C=C4N3)S(=O)(=O)[O-])=C3)C3=NC2=C1 SZGZILRQIYNODJ-UHFFFAOYSA-L 0.000 claims 1
- 210000000744 eyelid Anatomy 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 210000004556 brain Anatomy 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 230000004089 microcirculation Effects 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 238000000053 physical method Methods 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 2
- 206010002482 Angiosclerosis Diseases 0.000 abstract 1
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 abstract 1
- 235000017491 Bambusa tulda Nutrition 0.000 abstract 1
- 201000006474 Brain Ischemia Diseases 0.000 abstract 1
- 235000009467 Carica papaya Nutrition 0.000 abstract 1
- 241000219172 Caricaceae Species 0.000 abstract 1
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 244000082204 Phyllostachys viridis Species 0.000 abstract 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 abstract 1
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 abstract 1
- 244000185386 Thladiantha grosvenorii Species 0.000 abstract 1
- 239000011425 bamboo Substances 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 210000004351 coronary vessel Anatomy 0.000 abstract 1
- 230000001490 effect on brain Effects 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000002075 main ingredient Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 6
- 208000026106 cerebrovascular disease Diseases 0.000 description 5
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000008394 flocculating agent Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 208000023589 ischemic disease Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Abstract
The invention relates to a preparation and method for preventing and treating cerebral apoplexy (cerebral stroke) through eye dosing. The preparation is a traditional Chinese medicine drop for improving microcirculation of the brain. A preparing method of the preparation includes the steps that pseudo-ginseng, momordica grosvenori, bamboo fungus, red flowers, coptis chinensis, cordyceps sinensis, American ginseng, gynostemma pentaphylla, green papayas, liquorice, pericarpium citri reticulatae and the like are smashed, then cozy queen water is added, after PH is adjusted, extracting is carried out through ultrasonic waves form 6 hours, and the temperature of 38 DEG C is kept; after filtering is carried out through active carbon, sterilizing and filling are carried out on the preparation. The preparation and method have the advantages that the pure natural traditional Chinese medicinal materials are adopted, the traditional Chinese medicinal materials for promoting blood circulation to remove blood stasis serve as main ingredients of the preparation, and no preservative and chemical medicine is added; as preparing is carried out with a physical method, the micromolecule nanoscale activity standard is met; the long-term use effect on recovering of cerebral thrombosis sequelae and cerebral apoplexy sequelae is stable, and the effect on preventing hypertension, atherosclerosis of the coronary artery and angiosclerosis of the cerebral artery and the fundus artery which are inducements of the cerebral apoplexy is obvious. By means of the method, the microcirculation of the brain can be remarkably improved to treat the cerebral apoplexy, and the remarkably effect on brain ischemic diseases is achieved.
Description
Technical field the present invention relates to a kind of preparation and method of being prevented and treated apoplexy (apoplexy) by dosing eyes, and this invention is that one improves the microcirculatory Chinese medicine drop of brain, belongs to technical field of Chinese medicines.
Background technology apoplexy (apoplexy) does not well prevent in medical circle, the method for the treatment of and rehabilitation, the burst of mortality rate of apoplexy (apoplexy) is high, disability rate is high, the present invention is mainly for the prevention of apoplexy (apoplexy) and its inducement, treatment, the generation of prevention cerebral hemorrhage and cerebral thrombosis, to its inducement hypertension, coronary atherosclerosis, cerebral artery vessel hardens and Fundus oculi artery is angiosclerotic improves successful, especially to cerebral infarction Be very effective, relatively oral absorption energy efficiency is high, can not by the destruction such as gastric acid and trypsin, relatively intravenous injection and drop have and filter without Liver and kidney, easy breakthrough brain barrier, especially venothrombotic improvement is obviously given prominence to, change the convention of artery administration, the absorption of mucosa reaches the effect of getting twice the result with half the effort than intravenously administrable.
Cardiovascular and cerebrovascular disease is first killer of the mankind, and the present invention thoroughly can change the mankind and cannot prevent and the embarrassed look of not easily rehabilitation in the face of cerebrovascular disease, can shorten the time of Patients with Cardiovascular/Cerebrovascular Diseases rehabilitation.
Summary of the invention the object of the invention is to change route of administration, be that the Chinese medicine of master is through processing blood circulation promoting and blood stasis dispelling, by eye (canthus and palpebra interna) administration, dissolve brain thrombosis, improve the microcirculatory function of brain and add nutritive effect to cranial nerve, thus provide a kind of method of prevention, treatment and the rehabilitation of help cerebrovascular disease.
The present invention adopts the Chinese medicine of pure natural, does not add any antiseptic, flocculating agent and chemical drugs, only adopts physical method to produce.
(1) preparation method of the present invention is: by Radix Notoginseng, Fructus Momordicae, Flos Carthami, Caulis Bambusae In Taeniam, Rhizoma Coptidis, Hemsleya sphaerocarpa Kuang et A. M. Lu, Herba Tagetis Patulae, Flos Osmanthi Fragrantis, Cordyceps, Radix Panacis Quinquefolii, Pheretima, Squama Manis, Agkistrodon halys, Herb Gynostemmae Pentaphylli, nonage Fructus Chaenomelis, Radix Glycyrrhizae, Pericarpium Citri Reticulatae, first pulverize, then bar horse spring water is added, add brown sugar, lactobacillus, acetic acid bacteria and Aspergillus niger, carry out constant temperature 30 degree of fermentations 3 days, after PH adjustment, 1: 10 with distillate dilution, and with ultrasonic extraction 6 hours, temperature remained on 38 degree.Carry out ozone sterilization again 30 minutes, last activated carbon filtration, after filtering, preparation is through the fill of second time ozone sterilization.
The present invention has following distinguishing feature:
(2) this formulation chemist stable in properties, long term storage is never degenerated;
(3) the inducement hypertension of apoplexy, coronary atherosclerosis, cerebral arteries and the angiosclerotic successful of Fundus oculi artery is prevented;
(4) patient's permanence operation of rehabilitation is needed to stablize to cerebral thrombosis, apoplexy sequela etc.;
(5) edema of blood loss apoplexy is improved significantly;
(6) the inventive method significantly can improve the microcirculation of brain, reduces ectocinerea district, has act on more significantly cerebral ischemic disease;
Detailed description of the invention the following stated embodiment describes the present invention in detail
Embodiment 1 is by Radix Notoginseng, Fructus Momordicae, Caulis Bambusae In Taeniam, Flos Carthami, Rhizoma Coptidis, Hemsleya sphaerocarpa Kuang et A. M. Lu, Herba Tagetis Patulae, Flos Osmanthi Fragrantis, Cordyceps, Radix Panacis Quinquefolii, Pheretima, Squama Manis, Agkistrodon halys, Herb Gynostemmae Pentaphylli, nonage Fructus Chaenomelis, Radix Glycyrrhizae, Pericarpium Citri Reticulatae is respectively got 25 grams and is first carried out being ground into 100 orders, then bar horse spring water is added with 1: 9, add 100 grams, brown sugar, lactobacillus, acetic acid bacteria and Aspergillus niger 8 grams, carry out constant temperature 30 degree fermentation 3-10 days, after PH is adjusted to 7.25-7.45, with distillate dilute at 1: 10, again-use ultrasonic extraction 6 hours, ultrasonic extraction frequency is at 50-100KHZ, temperature remains on about 38 degree.Carry out ozone sterilization again 30 minutes, ozone concentration is at 0.5-5.0MG/L.Last activated carbon filtration, pharmaceutical filtration precision is between 100-10000 dalton, and after filtering, preparation is through the fill of second time ozone sterilization, the cerebral artery vessel sclerosis of prevention apoplexy inducement, insomnia etc.; Implementation method: every day 1-3 time, takes effect in one month by each 1 to 4, within three months, obviously improves, six months effect stabilities;
Radix Notoginseng, Fructus Momordicae, Caulis Bambusae In Taeniam, Flos Carthami, Hemsleya sphaerocarpa Kuang et A. M. Lu, Herba Tagetis Patulae, Flos Osmanthi Fragrantis, Cordyceps, Radix Panacis Quinquefolii, Pheretima, Squama Manis, Agkistrodon halys, Herb Gynostemmae Pentaphylli, nonage Fructus Chaenomelis, Radix Glycyrrhizae, Pericarpium Citri Reticulatae are respectively got 25 grams and are first carried out being ground into 100 orders by embodiment 2, then bar horse spring water is added with 1: 9, add 100 grams, brown sugar, lactobacillus, acetic acid bacteria and Aspergillus niger 8 grams, carry out constant temperature 30 degree fermentation 3-10 days, after PH is adjusted to 7.25-7.45, with distillate dilute at 1: 10, again-use ultrasonic extraction 6 hours, ultrasonic extraction frequency is at 50-100KHZ, and temperature remains on about 38 degree.Carry out ozone sterilization again 30 minutes, ozone concentration is at 0.5-5.0MG/L.Last activated carbon filtration, pharmaceutical filtration precision is between 100-10000 dalton, and after filtering, preparation is through the fill of second time ozone sterilization, the coronary atherosclerosis of prevention apoplexy inducement, coronary heart disease etc.; Implementation method: every day 1-3 time, has clear improvement in three months by each 1 to 5;
Radix Notoginseng, Fructus Momordicae, Caulis Bambusae In Taeniam, Flos Carthami, Rhizoma Coptidis, Hemsleya sphaerocarpa Kuang et A. M. Lu, Flos Osmanthi Fragrantis, Cordyceps, Radix Panacis Quinquefolii, Pheretima, Squama Manis, Agkistrodon halys, nonage Fructus Chaenomelis, Radix Glycyrrhizae, Pericarpium Citri Reticulatae are respectively got 25 grams and are first carried out being ground into 100 orders by embodiment 3, then bar horse spring water is added with 1: 9, add 100 grams, brown sugar, lactobacillus, acetic acid bacteria and Aspergillus niger 8 grams, carry out constant temperature 30 degree fermentation 3-10 days, after PH is adjusted to 7.25-7.45, with distillate dilute at 1: 10, again-use ultrasonic extraction 6 hours, ultrasonic extraction frequency is at 50-100KHZ, and temperature remains on about 38 degree.Carry out ozone sterilization again 30 minutes, ozone concentration is at 0.5-5.0MG/L.Last activated carbon filtration, pharmaceutical filtration precision is between 100-10000 dalton, and after filtering, preparation is through the fill of second time ozone sterilization, the Fundus oculi artery sclerosis of blood vessels of prevention apoplexy inducement, headache etc.; Implementation method: every day 1-3 time, each 1 to 2, one month takes effect, and within three months, obviously improves;
Radix Notoginseng, Fructus Momordicae, Caulis Bambusae In Taeniam, Rhizoma Coptidis, Hemsleya sphaerocarpa Kuang et A. M. Lu, Herba Tagetis Patulae, Flos Osmanthi Fragrantis, Cordyceps, Radix Panacis Quinquefolii, Pheretima, Agkistrodon halys, Herb Gynostemmae Pentaphylli, nonage Fructus Chaenomelis, Radix Glycyrrhizae, Pericarpium Citri Reticulatae are respectively got 25 grams and are first carried out being ground into 100 orders by embodiment 4, then bar horse spring water is added with 1: 9, add 100 grams, brown sugar, lactobacillus, acetic acid bacteria and Aspergillus niger 8 grams, carry out constant temperature 30 degree fermentation 3-10 days, after PH is adjusted to 7.25-7.45, with distillate dilute at 1: 10, again-use ultrasonic extraction 6 hours, ultrasonic extraction frequency is at 50-100KHZ, and temperature remains on about 38 degree.Carry out ozone sterilization again 30 minutes, ozone concentration is at 0.5-5.0MG/L.Last activated carbon filtration, pharmaceutical filtration precision is between 100-10000 dalton, and after filtering, preparation is through the fill of second time ozone sterilization, the hypertension etc. of prevention apoplexy inducement; Implementation method: every day 1-4 time, each 1 to 3, obviously improves, within six months, stablizes for three months.
Radix Notoginseng, Fructus Momordicae, Caulis Bambusae In Taeniam, Rhizoma Coptidis, Hemsleya sphaerocarpa Kuang et A. M. Lu, Herba Tagetis Patulae, Flos Osmanthi Fragrantis, Cordyceps, Radix Panacis Quinquefolii, Pheretima, Squama Manis, Herb Gynostemmae Pentaphylli, Radix Glycyrrhizae, Pericarpium Citri Reticulatae are respectively got 25 grams and are first carried out being ground into 100 orders by embodiment 5, then bar horse spring water is added with 1: 9, add 100 grams, brown sugar, lactobacillus, acetic acid bacteria and Aspergillus niger 8 grams, carry out constant temperature 30 degree fermentation 3-10 days, after PH is adjusted to 7.25-7.45, with distillate dilute at 1: 10, again-use ultrasonic extraction 6 hours, ultrasonic extraction frequency is at 50-100KHZ, and temperature remains on about 38 degree.Carry out ozone sterilization again 30 minutes, ozone concentration is at 0.5-5.0MG/L.Last activated carbon filtration, pharmaceutical filtration precision is between 100-10000 dalton, after filtering, preparation is through the fill of second time ozone sterilization, treatment apoplexy and cerebral thrombosis, implementation method: for blood loss Patients with Stroke, use after 48 hours, ischemia apoplexy patient can use the same day, every day 1-6 time, each 1 to 4, instant effect, successful and stablizing.
Embodiment 3 is by Radix Notoginseng, Fructus Momordicae, Caulis Bambusae In Taeniam, Flos Carthami, Rhizoma Coptidis, Hemsleya sphaerocarpa Kuang et A. M. Lu, Herba Tagetis Patulae, Flos Osmanthi Fragrantis, Cordyceps, Radix Panacis Quinquefolii, Pheretima, Squama Manis, Agkistrodon halys, Herb Gynostemmae Pentaphylli, nonage Fructus Chaenomelis, Radix Glycyrrhizae, Pericarpium Citri Reticulatae is respectively got 25 grams and is first carried out being ground into 100 orders, then bar horse spring water is added with 1: 9, add 100 grams, brown sugar, lactobacillus, acetic acid bacteria and Aspergillus niger 8 grams, carry out constant temperature 30 degree fermentation 3-10 days, after PH is adjusted to 7.25-7.45, with distillate dilute at 1: 10, again-use ultrasonic extraction 6 hours, ultrasonic extraction frequency is at 50-100KHZ, temperature remains on about 38 degree.Carry out ozone sterilization again 30 minutes, ozone concentration is at 0.5-5.0MG/L.Last activated carbon filtration, pharmaceutical filtration precision is between 100-10000 dalton, and after filtering, preparation is through the fill of second time ozone sterilization, help the rehabilitation of cerebral apoplexy sequela patient, implementation method: every day 1-4 time, each 1 to 4, instant effect, after three months, successful is stablized.
Claims (4)
1. prevented and treated preparation and the method for apoplexy (apoplexy) by dosing eyes for one kind, it is characterized in that with Radix Notoginseng, Fructus Momordicae, Caulis Bambusae In Taeniam, Flos Carthami, Rhizoma Coptidis, Hemsleya sphaerocarpa Kuang et A. M. Lu, Herba Tagetis Patulae, Flos Osmanthi Fragrantis, Cordyceps, Radix Panacis Quinquefolii, Pheretima, Squama Manis, Agkistrodon halys, Herb Gynostemmae Pentaphylli, nonage Fructus Chaenomelis, Radix Glycyrrhizae, Pericarpium Citri Reticulatae is respectively got 25 grams and is first carried out being ground into 100 orders, then bar horse spring water is added with 1: 9, add 100 grams, brown sugar, lactobacillus, acetic acid bacteria and Aspergillus niger 8 grams, carry out constant temperature 30 degree fermentation 3-10 days, after PH is adjusted to 7.25-7.45, with distillate dilute at 1: 10, again-use ultrasonic extraction 6 hours, ultrasonic extraction frequency is at 50-100KHZ, temperature remains on about 38 degree.Carry out ozone sterilization again 30 minutes, ozone concentration is at 0.5-5.0MG/L.Last activated carbon filtration, pharmaceutical filtration precision is between 100-10000 dalton.After filtering, preparation is through the fill of second time ozone sterilization.
2. one according to claim 1 prevents and treats the method for apoplexy (apoplexy) by dosing eyes, it is characterized in that: the ingredient told, based on blood-activating and stasis-removing, is especially attached most importance to Radix Notoginseng, Fructus Momordicae, Herba Saussureae Involueratae, Pheretima, Squama Manis, Agkistrodon halys.
3. one according to claim 1 prevents and treats the method for apoplexy (apoplexy) by dosing eyes, it is characterized in that: the dosing eyes told, and comprises being not limited only to ophthalmic and holding back, canthus, Jingming acupoint, upper lower eyelid.
4. one according to claim 1 prevents and treats the method for apoplexy (apoplexy) by dosing eyes, it is characterized in that: the control apoplexy (apoplexy) told, comprise be not limited only to prevent apoplexy inducement hypertension, coronary atherosclerosis, cerebral artery vessel sclerosis and Fundus oculi artery sclerosis of blood vessels, treatment apoplexy and cerebral thrombosis, help the rehabilitation of cerebral apoplexy sequela.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410281172.0A CN105194014A (en) | 2014-06-23 | 2014-06-23 | Preparation and method for preventing and treating cerebral apoplexy (cerebral stroke) through eye dosing |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410281172.0A CN105194014A (en) | 2014-06-23 | 2014-06-23 | Preparation and method for preventing and treating cerebral apoplexy (cerebral stroke) through eye dosing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105194014A true CN105194014A (en) | 2015-12-30 |
Family
ID=54942200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410281172.0A Pending CN105194014A (en) | 2014-06-23 | 2014-06-23 | Preparation and method for preventing and treating cerebral apoplexy (cerebral stroke) through eye dosing |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105194014A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103463256A (en) * | 2013-08-06 | 2013-12-25 | 卢金贵仙 | Cerebral stroke (cerebrovascular accident) treatment traditional Chinese medicine composition |
| CN103664992A (en) * | 2012-09-25 | 2014-03-26 | 韩冰 | Compounds for treating ischemic brain injury and application thereof |
-
2014
- 2014-06-23 CN CN201410281172.0A patent/CN105194014A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103664992A (en) * | 2012-09-25 | 2014-03-26 | 韩冰 | Compounds for treating ischemic brain injury and application thereof |
| CN103463256A (en) * | 2013-08-06 | 2013-12-25 | 卢金贵仙 | Cerebral stroke (cerebrovascular accident) treatment traditional Chinese medicine composition |
Non-Patent Citations (1)
| Title |
|---|
| 程发峰等: "清热解毒法治疗急性缺血性中风的系统综述", 《中药药理与临床》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106822316A (en) | A kind of invigorate blood circulation smokeless moxibustion bar and preparation method thereof | |
| CN102240382A (en) | Traditional Chinese medicine for treating mammary gland hyperplasia | |
| CN102225100A (en) | Chinese medicinal formulation for treating cardiovascular and cerebrovascular diseases and preparation process of products thereof | |
| CN102068527A (en) | Medicine and treatment method for eradication of whelk | |
| CN105362337B (en) | A kind of Chinese medicine composition with heat-clearing dissipating bind function, preparation and preparation method thereof | |
| CN104721559A (en) | Traditional Chinese medicine composition for treating oral ulcer | |
| CN105194014A (en) | Preparation and method for preventing and treating cerebral apoplexy (cerebral stroke) through eye dosing | |
| CN108126021B (en) | Traditional Chinese medicine mouth wash for treating kidney deficiency type loose and floating tooth and falling off and preparation method thereof | |
| CN102846928A (en) | A Chinese medicinal formulation for treating coronary heart disease | |
| CN105343660A (en) | Traditional Chinese medicinal preparation for treating peripheral vertigo and preparation method of traditional Chinese medicinal preparation | |
| CN105125639A (en) | Traditional Chinese medicine composition for preventing and treating mastitis of dairy cattle | |
| CN101653474B (en) | Medicine for treating hemorrhoid and its preparing process | |
| CN101518579B (en) | Pressure stabilizing deoppilant and preparation process | |
| CN1403119A (en) | Medicine for treating cerebral thrombus and its prepn | |
| CN105796927B (en) | A kind of Chinese medicine composition for treating blepharospasm | |
| CN103494941B (en) | Traditional Chinese medicine composite for treating pharyngitis and preparation method thereof and application thereof | |
| CN107095977A (en) | A kind of medicament and its pharmaceutical formulation and preparation method with the malicious effect of fire row of dispelling | |
| CN105267939A (en) | Traditional Chinese medicine composition for treating superficial phlebitis | |
| CN117224651A (en) | Preparation method of medicament for promoting blood circulation to remove blood stasis | |
| CN104208597A (en) | Chinese medicinal formula for treating kidney stone | |
| CN105031364A (en) | Preparation for preventing and treating toothache due to wind-fire evil and preparation method of preparation | |
| CN104800385A (en) | Traditional Chinese medicine for treating recurrent erysipelas | |
| CN103083403A (en) | Herbal composition for lowering likelihood of stroke and methods for healing stroke patients | |
| CN114831920A (en) | Novel external composition for rapidly preventing alopecia, stopping alopecia, removing dandruff, nourishing hair and growing hair | |
| CN110269227A (en) | Dedicated dietary supplements of bacillary dysentery patient and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Zhong Document name: Notification of Publication and of Entering the Substantive Examination Stage of the Application for Invention |
|
| DD01 | Delivery of document by public notice |
Addressee: Wang Zhong Document name: the First Notification of an Office Action |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Zhong Document name: Notification to Go Through Formalities Rectification of Restoration of Right |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Zhong Document name: Notification of Decision on Request for Restoration of Right |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Zhong Document name: Notification of an Office Action |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Zhong Document name: Notification that Application Deemed to be Withdrawn |
|
| DD01 | Delivery of document by public notice | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151230 |
|
| WD01 | Invention patent application deemed withdrawn after publication |